A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus
NCT01707147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3219
Last updated 2019-01-11
Summary
The aim of this study is to monitor safety and efficacy of treatment with linagliptin in Korean patients with type 2 diabetes mellitus in routine clinical settings.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
Trajenta tablet
Linagliptin
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-16
- Primary Completion
- 2017-07-11
- Completion
- 2017-07-11
Countries
- South Korea
More Related Trials
-
Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin
NCT02197078 ·Status: COMPLETED
-
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
NCT03011177 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes
NCT01084005 ·Status: COMPLETED ·Phase: PHASE3
-
Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
NCT00996658 ·Status: COMPLETED ·Phase: PHASE3
-
Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns
NCT02138097 ·Status: COMPLETED
-
Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment
NCT01903070 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
NCT02851745 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
NCT00819091 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes
NCT01734785 ·Status: COMPLETED ·Phase: PHASE3
-
Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus
NCT05290506 ·Status: COMPLETED ·Phase: PHASE3
-
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
NCT02551874 ·Status: COMPLETED ·Phase: PHASE3
-
Tenelia Triple Combination Study
NCT02567994 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes
NCT01855087 ·Status: COMPLETED
-
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
NCT00716092 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Glycemic Effectiveness of Linagliptin
NCT03338803 ·Status: COMPLETED
-
Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
NCT05303857 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)
NCT01703286 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
NCT00736099 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
NCT01907854 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.
NCT03169959 ·Status: COMPLETED ·Phase: PHASE1
-
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
NCT01897532 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Evaluate the Efficacy and Safety of Teneligliptin
NCT03793023 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
NCT06982859 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient
NCT02182895 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus
NCT02077309 ·Status: TERMINATED ·Phase: PHASE3